These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12190870)

  • 21. Hypertrophic scar tissues and fibroblasts produce more transforming growth factor-beta1 mRNA and protein than normal skin and cells.
    Wang R; Ghahary A; Shen Q; Scott PG; Roy K; Tredget EE
    Wound Repair Regen; 2000; 8(2):128-37. PubMed ID: 10810039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced vascularization of cultured skin substitutes genetically modified to overexpress vascular endothelial growth factor.
    Supp DM; Supp AP; Bell SM; Boyce ST
    J Invest Dermatol; 2000 Jan; 114(1):5-13. PubMed ID: 10620108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of transforming growth factor-beta and extracellular matrix by human peritoneal mesothelial cells and by fibroblasts from normal peritoneum and adhesions: effect of Tisseel.
    Saed GM; Kruger M; Diamond MP
    Wound Repair Regen; 2004; 12(5):557-64. PubMed ID: 15453838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of TGF-beta1 expression may be necessary but is not sufficient for excessive scarring.
    Campaner AB; Ferreira LM; Gragnani A; Bruder JM; Cusick JL; Morgan JR
    J Invest Dermatol; 2006 May; 126(5):1168-76. PubMed ID: 16498396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depletion of polyamines and increase of transforming growth factor-beta1, c-myc, collagen-type I, matrix metalloproteinase-1, and metalloproteinase-2 mRNA in primary human gingival fibroblasts.
    Stabellini G; Moscheni C; Gagliano N; Dellavia C; Calastrini C; Ferioli ME; Gioia M
    J Periodontol; 2005 Mar; 76(3):443-9. PubMed ID: 15857080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Collagenase 3 (matrix metalloproteinase 13) gene expression by HaCaT keratinocytes is enhanced by tumor necrosis factor alpha and transforming growth factor beta.
    Johansson N; Westermarck J; Leppä S; Häkkinen L; Koivisto L; López-Otín C; Peltonen J; Heino J; Kähäri VM
    Cell Growth Differ; 1997 Feb; 8(2):243-50. PubMed ID: 9040946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
    Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stress-relaxation and contraction of a collagen matrix induces expression of TGF-beta and triggers apoptosis in dermal fibroblasts.
    Varedi M; Tredget EE; Ghahary A; Scott PG
    Biochem Cell Biol; 2000; 78(4):427-36. PubMed ID: 11012081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts.
    Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY
    J Plast Reconstr Aesthet Surg; 2010 Jul; 63(7):1209-16. PubMed ID: 19617014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of recombinant adenovirus co-expression vector carrying the human transforming growth factor-beta1 and vascular endothelial growth factor genes and its effect on anterior cruciate ligament fibroblasts.
    Wei XL; Lin L; Hou Y; Fu X; Zhang JY; Mao ZB; Yu CL
    Chin Med J (Engl); 2008 Aug; 121(15):1426-32. PubMed ID: 18959121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of matrix metalloproteinases in cyclosporin-treated gingival fibroblasts is regulated by transforming growth factor (TGF)-beta1 autocrine stimulation.
    Cotrim P; de Andrade CR; Martelli-Junior H; Graner E; Sauk JJ; Coletta RD
    J Periodontol; 2002 Nov; 73(11):1313-22. PubMed ID: 12479636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes.
    Salo T; Lyons JG; Rahemtulla F; Birkedal-Hansen H; Larjava H
    J Biol Chem; 1991 Jun; 266(18):11436-41. PubMed ID: 1646806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelin 1 contributes to the effect of transforming growth factor beta1 on wound repair and skin fibrosis.
    Lagares D; García-Fernández RA; Jiménez CL; Magán-Marchal N; Busnadiego O; Lamas S; Rodríguez-Pascual F
    Arthritis Rheum; 2010 Mar; 62(3):878-89. PubMed ID: 20131241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling.
    Berking C; Takemoto R; Schaider H; Showe L; Satyamoorthy K; Robbins P; Herlyn M
    Cancer Res; 2001 Nov; 61(22):8306-16. PubMed ID: 11719464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential gene expression in response to transforming growth factor-beta1 by fetal and postnatal dermal fibroblasts.
    Rolfe KJ; Irvine LM; Grobbelaar AO; Linge C
    Wound Repair Regen; 2007; 15(6):897-906. PubMed ID: 18028139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dermal fibroblasts are one of the therapeutic targets for topical application of 1alpha,25-dihydroxyvitamin D3: the possible involvement of transforming growth factor-beta induction.
    Oyama N; Iwatsuki K; Satoh M; Akiba H; Kaneko F
    Br J Dermatol; 2000 Dec; 143(6):1140-8. PubMed ID: 11122013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
    Fujiwara M; Muragaki Y; Ooshima A
    Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of dermal fibrosis in self-assembled skin equivalents by undifferentiated keratinocytes.
    Wang X; Liu Y; Deng Z; Dong R; Liu Y; Hu S; Li Y; Jin Y
    J Dermatol Sci; 2009 Feb; 53(2):103-11. PubMed ID: 18990546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).
    Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD
    Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.